Since 2010, when Botox was approved by the FDA for migraines that occur at least 15 days out of the month, Jason Krutsch, MD, has used the treatment on dozens of patients.
“Botox significantly impacts patients with chronic migraine headache,” said Dr. Krutsch, who serves as director of Interventional Pain Management at the University of Colorado Denver in the Anschutz Outpatient Pavilion. “Some benefit more than others, but in general, patients are able to function better, sleep better, mood is elevated, depression and anxiety are lessened, and migraines have decreased by nine days per month in most patients.”
Related Articles on Pain Management:
Kentucky Pain Bill Passes House
One Third of Cancer Patients Receive Inadequate Pain Treatment
The Digital Doctor: How to Harness the Internet’s Power to Enhance Patient Relationships and Practice Revenue
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
